Drug combinations for the treatment of Duchenne muscular dystrophy

Details for Australian Patent Application No. 2008285290 (hide)

Owner Summit Corporation PLC

Inventors Nugent, Gary; Pye, Richard Joseph; Wynne, Graham Michael; Dorgan, Colin Richard; De Moor, Olivier; Johnson, Peter David; Wren, Stephen Paul; Storer, Richard; Price, Paul Damien

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008285290

PCT Pub. Number WO2009/019505

Priority 0715087.3 03.08.07 GB

Filing date 1 August 2008

Wipo publication date 12 February 2009

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61K 31/4192 (2006.01) - 1,2,3-Triazoles

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 21/00 (2006.01) Drugs for disorders of the muscular or neuromuscular system

Event Publications

10 December 2009 PCT application entered the National Phase

  PCT publication WO2009/019505 Priority application(s): WO2009/019505

11 March 2010 Assignment before Grant

  Summit Corporation PLC The application has been assigned to Biomarin IGA Limited

22 April 2010 Corrigenda

  Assignments Before Grant, Section 113 - 2008 Under the name Biomarin IGA Limited, Application No. 2008285290, under INID(71), correct the applicant name to BioMarin IGA Limited

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008285300-Connector

2008285289-Drug combinations for the treatment of Duchenne muscular dystrophy